Literature DB >> 21795591

Phagocytosis, a potential mechanism for myeloid-derived suppressor cell regulation of CD8+ T cell function mediated through programmed cell death-1 and programmed cell death-1 ligand interaction.

Young-June Kim1, Su-Jung Park, Hal E Broxmeyer.   

Abstract

CD8(+) T cells become exhausted, inducing cell surface protein programmed cell death-1 (PD-1) as chronic virus diseases or tumors progress, but underlying mechanisms of this are unclear. We previously showed that M-CSF is important for developing tolerogenic dendritic cells (DCs) from human CD14(+) monocytes. In this article, we identify M-CSF-derived DCs (M-DCs) after stimulation with IL-10 as myeloid-derived suppressor cells with additional tolerogenic activities to CD8(+) T cells. IL-10 increased PD-1 ligand expression on M-DC, and IL-10-stimulated M-DCs (M-DC/IL-10) induced expression of PD-1 on, and apoptosis of, CD8(+) T cells and phagocytosed CD8(+) T cells. Enhanced phagocytic activity of M-DC/IL-10 required IFN-γ, which further increased PD-1 ligand and PD-2 ligand expression on M-DC/IL-10. IFN-γ-stimulated M-DC/IL-10 cells were phenotypically macrophage-like cells with little or no expression of CD86, a costimulatory molecule, but with high expression levels of CD14, CD200R, and CD80. No phagocytic activity was detected with GM-CSF-derived DCs. We propose that phagocytosis by IFN-γ-stimulated M-DC/IL-10 cells, which may be DCs or, alternatively, a unique subset of macrophages, may be a mechanism by which IFN-γ-producing CD8(+) T cells are tolerized after type 1 immune responses to chronic virus or tumor, and that IFN-γ links effector CD8(+) T cells to their phagocytic clearance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21795591      PMCID: PMC3159723          DOI: 10.4049/jimmunol.1002650

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  59 in total

Review 1.  Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity.

Authors:  Lieping Chen
Journal:  Nat Rev Immunol       Date:  2004-05       Impact factor: 53.106

2.  B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes.

Authors:  Haidong Dong; Gefeng Zhu; Koji Tamada; Dallas B Flies; Jan M A van Deursen; Lieping Chen
Journal:  Immunity       Date:  2004-03       Impact factor: 31.745

3.  Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4.

Authors:  Hans Christian Probst; Kathy McCoy; Taku Okazaki; Tasuku Honjo; Maries van den Broek
Journal:  Nat Immunol       Date:  2005-01-30       Impact factor: 25.606

Review 4.  Immunosuppressive networks in the tumour environment and their therapeutic relevance.

Authors:  Weiping Zou
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

5.  Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

Authors:  Tyler J Curiel; Shuang Wei; Haidong Dong; Xavier Alvarez; Pui Cheng; Peter Mottram; Roman Krzysiek; Keith L Knutson; Ben Daniel; Maria Carla Zimmermann; Odile David; Matthew Burow; Alan Gordon; Nina Dhurandhar; Leann Myers; Ruth Berggren; Akseli Hemminki; Ronald D Alvarez; Dominique Emilie; David T Curiel; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2003-04-21       Impact factor: 53.440

6.  Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment.

Authors:  E John Wherry; Joseph N Blattman; Kaja Murali-Krishna; Robbert van der Most; Rafi Ahmed
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

7.  Phenotypic characterization of human decidual macrophages.

Authors:  J Heikkinen; M Möttönen; J Komi; A Alanen; O Lassila
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

8.  Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor.

Authors:  C Menetrier-Caux; G Montmain; M C Dieu; C Bain; M C Favrot; C Caux; J Y Blay
Journal:  Blood       Date:  1998-12-15       Impact factor: 22.113

9.  Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.

Authors:  Haidong Dong; Scott E Strome; Diva R Salomao; Hideto Tamura; Fumiya Hirano; Dallas B Flies; Patrick C Roche; Jun Lu; Gefeng Zhu; Koji Tamada; Vanda A Lennon; Esteban Celis; Lieping Chen
Journal:  Nat Med       Date:  2002-06-24       Impact factor: 53.440

10.  Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus.

Authors:  M Clerici; T A Wynn; J A Berzofsky; S P Blatt; C W Hendrix; A Sher; R L Coffman; G M Shearer
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

View more
  12 in total

1.  Natural killer cells promote immune tolerance by regulating inflammatory TH17 cells at the human maternal-fetal interface.

Authors:  Binqing Fu; Xianchang Li; Rui Sun; Xianhong Tong; Bin Ling; Zhigang Tian; Haiming Wei
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-27       Impact factor: 11.205

Review 2.  Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy.

Authors:  Takami Sato; Mizue Terai; Yutaka Tamura; Vitali Alexeev; Michael J Mastrangelo; Senthamil R Selvan
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

3.  Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils.

Authors:  Lauren A Licata; Cang T Nguyen; Rachel A Burga; Vincent Falanga; N Joseph Espat; Alfred Ayala; Mitchell Thorn; Richard P Junghans; Steven C Katz
Journal:  J Leukoc Biol       Date:  2013-07-24       Impact factor: 4.962

4.  Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma.

Authors:  Peng Zhang; Jason Miska; Catalina Lee-Chang; Aida Rashidi; Wojciech K Panek; Shejuan An; Markella Zannikou; Aurora Lopez-Rosas; Yu Han; Ting Xiao; Katarzyna C Pituch; Deepak Kanojia; Irina V Balyasnikova; Maciej S Lesniak
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-11       Impact factor: 11.205

Review 5.  Myeloid-derived suppressor cells participate in preventing graft rejection.

Authors:  Yan Wang; Xiaodong Gu; Jianbin Xiang; Zongyou Chen
Journal:  Clin Dev Immunol       Date:  2012-03-15

Review 6.  T-cell exhaustion in the tumor microenvironment.

Authors:  Y Jiang; Y Li; B Zhu
Journal:  Cell Death Dis       Date:  2015-06-18       Impact factor: 8.469

Review 7.  Macrophage-Mediated Subversion of Anti-Tumour Immunity.

Authors:  Valeria Quaranta; Michael C Schmid
Journal:  Cells       Date:  2019-07-19       Impact factor: 6.600

Review 8.  Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses.

Authors:  Clément Anfray; Aldo Ummarino; Fernando Torres Andón; Paola Allavena
Journal:  Cells       Date:  2019-12-23       Impact factor: 6.600

Review 9.  Biomechanics of T Cell Dysfunctions in Chronic Diseases.

Authors:  Sachith D Gunasinghe; Newton G Peres; Jesse Goyette; Katharina Gaus
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

Review 10.  Metabolic and epigenetic regulation of T-cell exhaustion.

Authors:  Fabien Franco; Alison Jaccard; Pedro Romero; Yi-Ru Yu; Ping-Chih Ho
Journal:  Nat Metab       Date:  2020-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.